Skyhawk news

Browse:

Skyhawk's proprietary platform revolutionizes disease treatment by developing small molecule therapeutics that modify RNA expression

December 22, 2020
$40M up front: Skyhawk takes flight with Vertex deal
Skyhawk Therapeutics Inc., one of the early leaders in developing small-molecule drugs that target RNA, closed out the year with yet another
Read
3 min read
December 22, 2020
A busy, buzzy Vertex finds a high-profile partner in the RNA-drugging world to launch a fresh ...
A busy, buzzy Vertex finds a high-profile partner in the RNA-drugging world to launch a fresh discovery effort
Read
2 min read
December 22, 2020
Vertex joins Skyhawk’s roster of A-list partners, securing options on RNA splicing modulators
Vertex will take full responsibility for development and commercialization of assets it licenses from Skyhawk Therapeutics.
Read
2 min read
September 30, 2020
The Endpoints 11 : Here are some of the most promising startups in biotech. And Covid-19 isn’t ...
The Endpoints 11 : Here are some of the most promising startups in biotech. And Covid-19 isn’t going to stop them John Carroll : Editor &...
Read
2 min read
May 12, 2020
Skyhawk Therapeutics boosts Merck collab pact with added targets, upfront and biobucks
Merck has decided to double down on its research pact with startup Skyhawk Therapeutics as it expands the deal to now also cover autoimmune
Read
2 min read